Study guide
8.1 Endocrine Assessment & Diabetes Management
ANCC Medical-Surgical Nursing Certification MEDSURG-BC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts: Format, Scoring, Cost 1.2 Eligibility, Application & Scheduling 1.3 Blueprint Breakdown & Study Strategy 1.4 Test-Taking Strategies for ANCC Scenario Items
2 Assessment Skills
2.1 Health History Collection 2.2 Physical Assessment 2.3 Psychosocial Assessment 2.4 Cognitive & Neurological Screening
3 Diagnostics & Clinical Reasoning
3.1 Diagnostic & Laboratory Testing 3.2 Fluids & Electrolytes 3.3 Nursing Diagnosis Identification & Prioritization
4 Cardiovascular & Hematologic
4.1 Cardiovascular Assessment & Diagnostics 4.2 Cardiovascular Disorders & Management 4.3 Hematologic Disorders & Blood Products
5 Respiratory
5.1 Respiratory Assessment & Diagnostics 5.2 Respiratory Disorders & Management 5.3 Oxygen Therapy & Ventilation Support
6 Gastrointestinal & Renal
6.1 GI Assessment & Common Disorders 6.2 GI Management & Nutrition Support 6.3 Renal & Urinary Assessment & Disorders 6.4 Acute Kidney Injury & Renal Replacement Therapies
7 Neurologic & Musculoskeletal
7.1 Neurologic Assessment & Stroke 7.2 Neurologic Disorders & Management 7.3 Musculoskeletal Assessment & Disorders 7.4 Orthopedic Care, Immobilization & Mobility
8 Endocrine, Integumentary & Immune
8.1 Endocrine Assessment & Diabetes Management 8.2 Thyroid, Adrenal & Metabolic Disorders 8.3 Integumentary Disorders & Wound Care 8.4 Immune, Infectious & Multisystem Conditions
9 Care Planning & Education
9.1 Nursing Care Planning 9.2 Patient Teaching: Process & Evaluation 9.3 Education Topics & Self-Management 9.4 Health & Wellness Promotion
10 Perioperative Care
10.1 Preoperative & Intraoperative Care 10.2 Postoperative Complication Prevention 10.3 Postoperative Emergencies: Bleeding, Infection, Emboli
11 Patient Safety
11.1 Patient Safety: Falls, Restraints & Equipment 11.2 Infection Prevention & Isolation Precautions 11.3 Recognizing Deterioration & Escalation of Care
12 Pharmacology
12.1 Safe Medication Administration 12.2 Interactions & Adverse Effects 12.3 Pain Management & Analgesics 12.4 Polypharmacy & High-Alert Medications
13 Non-Pharmacologic & Comfort Care
13.1 Non-Pharmacologic Treatments & CAM 13.2 Comfort & End-of-Life Care
14 Therapeutic Communication
14.1 Therapeutic Communication 14.2 Cultural Competence & Family-Centered Care 14.3 Difficult Conversations & Counseling
15 Interprofessional Collaboration
15.1 Interdisciplinary Team Collaboration 15.2 Delegation & Supervision 15.3 Care Coordination, Consults & Transitions
16 Ethics & Evidence-Based Practice
16.1 Nursing Ethics & Patient Advocacy 16.2 Legal & Regulatory Foundations 16.3 Evidence-Based Practice & Research 16.4 Quality Improvement & Safety Culture
8.1 Endocrine Assessment & Diabetes Management
Key Takeaways Explain This Topic AI
Diabetes is diagnosed by an A1C of 6.5% or higher, fasting plasma glucose of 126 mg/dL or higher, or a random glucose of 200 mg/dL or higher with classic symptoms
Rapid-acting insulin (lispro, aspart, glulisine) onsets in about 15 minutes and peaks near 1 hour; NPH peaks at 4-10 hours and is a classic cause of nocturnal hypoglycemia
Treat conscious hypoglycemia with the 15/15 rule: 15 grams of fast-acting carbohydrate, recheck in 15 minutes, repeat until glucose exceeds 70 mg/dL
Current DKA diagnosis requires diabetes or glucose at least 200 mg/dL, ketosis, and metabolic acidosis; HHS is defined by severe hyperglycemia and hyperosmolality without significant ketosis or acidosis
For both DKA and HHS, isotonic fluid resuscitation comes before insulin, and potassium must be verified above 3.5 mEq/L before starting an insulin infusion (2024 adult consensus)
Last updated: October 2026
Diabetes mellitus is the highest-yield endocrine topic on the MEDSURG-BC exam. Questions test your ability to interpret diagnostic labs, match insulin types to their action profiles, and prioritize care in the hyperglycemic emergencies.
Types of Diabetes
Type 1 diabetes mellitus (T1DM): Autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency. Onset is usually in childhood or young adulthood, patients are typically lean, and they are prone to diabetic ketoacidosis (DKA) . Lifelong insulin is required.
Type 2 diabetes mellitus (T2DM): Insulin resistance with progressive beta-cell dysfunction. Strong association with obesity and sedentary lifestyle; patients may be managed with oral agents, non-insulin injectables, or insulin. The characteristic emergency is hyperosmolar hyperglycemic state (HHS) .
Gestational diabetes: Glucose intolerance first recognized in pregnancy; resolves after delivery but increases future T2DM risk.
Prediabetes: A1C 5.7-6.4% or fasting glucose 100-125 mg/dL (impaired fasting glucose). This is a counseling and lifestyle-intervention window.
Diagnostic Criteria (American Diabetes Association)
Any one of the following, confirmed on a second day unless symptoms are unequivocal:
- Test Diabetes Prediabetes
- A1C 6.5% or higher 5.7-6.4%
- Fasting plasma glucose (8-hr fast) 126 mg/dL or higher 100-125 mg/dL
- 2-hr oral glucose tolerance test (75 g load) 200 mg/dL or higher 140-199 mg/dL
- Random glucose with classic symptoms (polyuria, polydipsia, weight loss) 200 mg/dL or higher N/A
Glycemic targets for most nonpregnant adults: fasting/premeal glucose 80-130 mg/dL, peak postprandial under 180 mg/dL, and A1C under 7%. For hospitalized and critically ill patients, target 140-180 mg/dL — tight control in the ICU increases hypoglycemia risk without outcome benefit.
Insulin Types: Onset, Peak, Duration
The exam frequently asks which insulin to hold when a patient is NPO, which to give for a glucose of 320 mg/dL right now, or why a patient on evening NPH wakes up hypoglycemic.
- Type Examples Onset Peak Duration
- Rapid-acting Lispro (Humalog), aspart (NovoLog), glulisine (Apidra) 10-15 min 1-2 hr 3-5 hr
- Short-acting Regular (Humulin R) 30-60 min 2-3 hr 5-8 hr
- Intermediate-acting NPH (Humulin N) 2-4 hr 4-10 hr 10-16 hr
- Long-acting Glargine (Lantus), detemir (Levemir) 1-2 hr None (peakless) Up to 24 hr
- Ultra-long-acting Degludec (Tresiba) 1-6 hr None Over 42 hr
- Insulin pearls
Only regular insulin is given IV — it is the insulin of choice for DKA and HHS drips.
Give rapid-acting insulin within 15 minutes of eating; giving it to a patient whose tray has not arrived causes hypoglycemia.
Long-acting basal insulin (glargine) is continued even when NPO , including for surgery; prandial (rapid/short-acting) insulin is held when the patient cannot eat.
When mixing insulins, draw clear before cloudy (regular before NPH).
NPH is the only insulin that looks cloudy; gently roll — do not shake — to resuspend it.
Hypoglycemia vs Hyperglycemia
Hypoglycemia is a blood glucose below 70 mg/dL and is the most immediately life-threatening glucose problem — treat it before anything else.
- Feature Hypoglycemia Hyperglycemia
- Onset Rapid (minutes) Gradual (hours-days)
- Skin Cool, clammy, diaphoretic Warm, dry, flushed
- Behavior Shakiness, irritability, confusion, seizure, coma Lethargy, weakness
Other signs Tachycardia, hunger, tremor Polyuria, polydipsia, blurred vision, fruity breath, Kussmaul respirations (DKA)
Glucose Below 70 mg/dL Often above 200 mg/dL; DKA also requires ketosis and acidosis
Memory aid: hypoglycemia signs are cold and clammy — need some candy . Severe signs (seizure, unconsciousness) reflect neuroglycopenia.
The 15/15 rule (conscious patient)
Give 15 grams of fast-acting carbohydrate : 4 oz fruit juice or regular soda, 3-4 glucose tablets, or 1 tablespoon of sugar or honey.
Recheck glucose in 15 minutes .
Repeat treatment until glucose is above 70 mg/dL.
If the next meal is more than an hour away, follow with a protein-and-carbohydrate snack.
Unconscious or NPO patient
Give glucagon 1 mg IM or subcutaneous (also available as intranasal), or 25 g of 50% dextrose (D50) IV .
Never give anything by mouth to a patient who cannot swallow.
Beta-blockers mask the adrenergic warning signs (tremor, tachycardia, palpitations) of hypoglycemia — sweating may be the only clue.
DKA vs HHS
- Feature DKA HHS
- Typical patient Type 1 Type 2 (often older adults)
- Glucose criterion At least 200 mg/dL or prior diabetes At least 600 mg/dL
- Serum pH Below 7.3 Above 7.3
- Bicarbonate Below 18 mEq/L Above 18 mEq/L
- Ketones Beta-hydroxybutyrate at least 3.0 mmol/L or urine ketones at least 2+ Absent or minimal
- Serum osmolality Variable Above 320 mOsm/kg
- Mental status Alert to stuporous Profound alteration, seizures, coma
- Onset Hours to a day Days to weeks
- Mortality Lower Higher (dehydration, comorbidity)
- Management priorities (both emergencies)
Fluids first: 0.9% sodium chloride or a balanced crystalloid at 500-1,000 mL/hr for the first 2-4 hours in adults without renal or cardiac compromise (smaller 250 mL boluses in older adults, heart failure, or dialysis). Fluid resuscitation restores perfusion and lowers glucose by dilution and improved renal clearance.
Regular insulin IV infusion at 0.1 units/kg/hr (DKA). Glucose should fall 50-70 mg/dL per hour; a slower drop suggests inadequate dosing or insulin resistance.
Potassium before or with insulin: Insulin drives potassium into cells, and acidosis masks total-body potassium depletion. If serum potassium is below 3.5 mEq/L, start potassium replacement and delay insulin until potassium rises above 3.5. When potassium is 3.5-5.0, replace potassium during treatment to maintain roughly 4-5 mEq/L.
Add 5-10% dextrose when glucose falls below 250 mg/dL and continue insulin until the ketoacidosis resolves (DKA is resolved when plasma ketone (β-hydroxybutyrate) is <0.6 mmol/L and venous pH is ≥7.3 or bicarbonate is ≥18 mEq/L (ideally glucose <200 mg/dL); the anion gap and urine ketones are not used as resolution criteria) — stopping insulin when glucose normalizes but acidosis persists causes rebound DKA.
Search for the trigger: infection, missed insulin, new diagnosis, myocardial infarction, drugs (corticosteroids).
Complication to watch: cerebral edema (especially in children and young adults) from overly rapid correction — report headache or decreasing level of consciousness immediately.
Sick-Day Rules
Illness raises counterregulatory hormones and glucose even when the patient is not eating. Teach patients to:
Never stop insulin — insulin needs typically increase during illness; omission is a leading cause of DKA.
Check glucose every 4 hours and check urine ketones when glucose exceeds 240-300 mg/dL (type 1).
Sip sugar-free fluids to prevent dehydration; if unable to tolerate solids, alternate sugar-containing fluids to cover insulin.
Call the provider for vomiting, ketones, glucose persistently above 300 mg/dL, or signs of dehydration.
Foot Care
Peripheral neuropathy plus peripheral arterial disease makes the diabetic foot a major source of morbidity. Teach daily foot inspection (use a mirror for soles), washing with lukewarm water and thorough drying between toes, never walking barefoot, avoiding heating pads and hot water bottles (burn risk with neuropathy), cutting nails straight across, and wearing properly fitted shoes. The nurse screens with a 10-g monofilament for protective sensation and palpates pedal pulses; patients need a professional foot exam at least annually.
Chronic Complications
Microvascular: Retinopathy (leading cause of adult blindness — annual dilated eye exam), nephropathy (microalbuminuria is the earliest sign; ACE inhibitors or ARBs are renoprotective), neuropathy (stocking-glove sensory loss, gastroparesis, neurogenic bladder).
Macrovascular: Coronary artery disease, stroke, peripheral arterial disease — the leading cause of death in T2DM. Aggressive blood pressure and lipid management (statins) matter as much as glucose control.
Perioperative Glucose Management
Continue basal insulin (often at 75-80% of the usual dose); hold prandial insulin while NPO.
Hold metformin the day of surgery (lactic acidosis risk with hemodynamic changes and contrast dye) and restart once renal function is confirmed.
Target glucose 140-180 mg/dL in surgical and critically ill patients; treat values above 180 with correction insulin and treat below 70 immediately.
Frequent monitoring is required because anesthesia masks hypoglycemia symptoms.